...
首页> 外文期刊>Drug Design, Development and Therapy >Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes
【24h】

Cryo-ablation improves anti-tumor immunity through recovering tumor educated dendritic cells in tumor-draining lymph nodes

机译:冷冻消融可通过在引流肿瘤的淋巴结中恢复受过肿瘤教育的树突状细胞来提高抗肿瘤免疫力

获取原文
           

摘要

Background: In addition to minimally invasive destruction of tumors, cryo-ablation of tumors to some extent modulated anti-tumor immunity. Cryo-ablated tumors in glioma mice models induced anti-tumor cellular immunologic response which increases the percentage of CD3+ and CD4+T cells in blood as well as natural killer cells. As a crucial role in triggering anti-tumor immunity, dendritic cells (DCs) were educated by tumors to adopt a tolerance phenotype which helps the tumor escape from immune monitoring. This study aims to study whether cryo-ablation could influence the tolerogenic DCs, and influence anti-tumor immunity in tumor-draining lymph nodes (TDLNs). Methods: Using the GL261 subcutaneous glioma mouse model, we created a tumor bearing group, cryo-ablation group, and surgery group. We analyzed alteration in phenotype and function of tolerogenic DCs, and evaluated the factors of anti-tumor immunity inhibition. Results: DCs in TDLNs in GL261 subcutaneous glioma mouse model expressed tolerogenic phenotype. In contrast to surgery, cryo-ablation improved the quantity and quality of these tolerogenic DCs. Moreover, the DCs decreased the expression of intracellular interleukin-10 (IL-10) and extra-cellular IL-10. In vitro, DCs from the cryo-ablation group recovered their specific function and induced potent anti-tumor immunity through triggering T cells. In vivo, cryo-ablation showed weak anti-tumor immunity, only inhibiting the growth of rechallenged tumors. But many IL-10-low DCs, rather than IL-10-high DCs, infiltrated the tumors. More importantly, Tregs inhibited the performance of these DCs; and depletion of Tregs greatly improved anti-tumor immunity in vivo. Conclusion: Cryo-ablation could recover function of tumor induced tolerogenic DCs in vitro; and depletion of Tregs could improve this anti-tumor effect in vivo. The Tregs/CD4+T and Tregs/CD25+T cells in TDLNs inhibit DCs’ activity and function.
机译:背景:除了对肿瘤的微创破坏,肿瘤的冷冻消融在一定程度上还调节了抗肿瘤免疫力。胶质瘤小鼠模型中的冷冻消融肿瘤诱导抗肿瘤细胞免疫反应,从而增加血液以及自然杀伤细胞中CD3 +和CD4 + T细胞的百分比。作为触发抗肿瘤免疫的关键作用,树突状细胞(DCs)受肿瘤教育而具有耐受表型,可帮助肿瘤摆脱免疫监测。这项研究旨在研究冷冻消融能否影响耐受性DC,并影响引流淋巴结(TDLN)的抗肿瘤免疫性。方法:使用GL261皮下神经胶质瘤小鼠模型,我们建立了荷瘤组,冷冻消融组和手术组。我们分析了致耐受性DC的表型和功能的变化,并评估了抗肿瘤免疫抑制的因素。结果:GL261皮下神经胶质瘤小鼠模型中TDLNs中的DCs表达耐受性表型。与手术相反,冷冻消融改善了这些致耐受性DC的数量和质量。此外,DC降低了细胞内白介素10(IL-10)和细胞外IL-10的表达。在体外,冷冻消融组的DC恢复了其特定功能,并通过触发T细胞诱导了强大的抗肿瘤免疫力。在体内,冷冻消融显示出弱的抗肿瘤免疫性,仅抑制再发肿瘤的生长。但是,许多IL-10低的DC而不是IL-10-高的DC浸润了肿瘤。更重要的是,Tregs抑制了这些DC的性能。以及Tregs的耗竭极大地提高了体内的抗肿瘤免疫力。结论:低温消融可在体外恢复肿瘤诱导的致耐受性DC的功能。 Tregs的消耗可以改善体内的这种抗肿瘤作用。 TDLNs中的Tregs / CD4 + T和Tregs / CD25 + T细胞抑制DC的活性和功能。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号